Price
$103.00-11.31%Social Signal Score
Analyst Ratings
43 analysts52-week range
- Last close
- $103.00
- Off 52w high
- -20.1%
- 200-day average
- $101.45
- vs 200-day
- +1.5%
Revenue
$13.01B+144.01%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Robert Ford
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 115,000
- Beta
- 0.54
- Country
- US
- Piotroski score
- 6 / 9 (Middling)
- Altman Z-score
- 3.28
Financials
Revenue
$13.01B+144.0%Net Income
$920.00M+15.3%EBITDA
$2.84B+152.2%Free Cash Flow
$1.22B+43.8%EPS (diluted)
$0.53-1.9%Shares Outstanding (diluted)
1.74B+17.2%Operating Expenses
$5.19BCash & Debt
$4.30BReturn of Capital
$1.10BRevenue by Segment (annual)
$44.31BDividend per Share
$0.63Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $44.33B | $6.52B | $3.74 |
| 2024 | $41.95B | $13.40B | $7.67 |
| 2023 | $40.11B | $5.72B | $3.30 |
| 2022 | $43.65B | $6.93B | $3.94 |
| 2021 | $43.08B | $7.07B | $3.97 |
| 2020 | $34.61B | $4.50B | $2.52 |
| 2019 | $31.90B | $3.69B | $2.07 |
| 2018 | $30.58B | $2.37B | $1.35 |
| 2017 | $27.39B | $477.00M | $0.27 |
| 2016 | $20.85B | $1.40B | $0.95 |
| 2015 | $20.41B | $4.42B | $3.00 |
| 2014 | $20.25B | $2.28B | $1.51 |
| 2013 | $21.85B | $2.58B | $1.66 |
| 2012 | $39.87B | $5.96B | $3.78 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from ABT's reported EPS growth of -0.1% a year over 13 years.
- EPS in 5 years
- $3.72
- Implied price
- $126.34
- Return from $103.00
- 4.2% a year
To earn 15.0% a year on these assumptions you'd need to buy at $62.81 — -39.0% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 24 | 29 | 34 | 39 | 44 |
|---|---|---|---|---|---|
| -10.1% | -12.6% | -9.2% | -6.3% | -3.7% | -1.3% |
| -5.1% | -7.7% | -4.1% | -1.0% | 1.7% | 4.2% |
| -0.1% | -2.8% | 0.9% | 4.2% | 7.1% | 9.7% |
| 4.9% | 2.0% | 6.0% | 9.4% | 12.4% | 15.2% |
| 9.9% | 6.9% | 11.0% | 14.6% | 17.8% | 20.7% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
50-9.79%Social Signal Score
Mentions (100)
- News247wallst.com·14h ago·Neutral
Abbott Has Raised Its Dividend for 54 Years. These 3 Healthcare Stocks Keep Paying More One dividend streak spans five decades, another company barely paid anything until 2021, and a third pays out a fraction of its earnings. Three healthcare payers raised income this year, but their safety margins look very different.
View source ↗ - News (RSS)zerohedge·1d ago·Neutral
Democrats Are About To Run 77% Of America's Data Center Pipeline Democrats Are About To Run 77% Of America's Data Center Pipeline Authored by Rystad Energy via OilPrice.com,Democratic governors will lead states accounting for 77% of the 300 GW of announced US data center capacity planned for 2027–2030. Rystad Energy forecasts 121 GW of additions during that period, with renewed Texas permitting restrictions potentially delaying approximately 3 GW. Tougher grid-connection requirements and long-te
View source ↗ - News247wallst.com·1d ago·Positive
Abbott Has Lost More Than 10% This Year, and $1,000 From Five Years Ago Is Worth Less Than $950 Abbott bought a $21 billion cancer screening business and still watched investors flee. A buyer from a decade ago is thrilled, but newer shareholders face a harder question about what finally turns the story around.
View source ↗ - Newsfool.com·3d ago·Positive
3 Dividend Kings to Buy in November and Never Sell Abbott boasts 54 straight years of dividend growth, and plans to spin off its troubled nutrition division could lead to a re-rating of the stock. McDonald's has raised its dividend for 50 years, and the stock should rebound further if turnaround efforts continue to improve results.
View source ↗ - Newsprnewswire.com·3d ago·Positive
…nt valve performance Encantor early feasibility study data will be presented at PCR London Valves 2026 ABBOTT PARK, Ill., Nov. 19, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), the global healthcare leader, announced today it has initiated the VOYAGER CE clinical trial evaluating the safety and efficacy of its investigational Encantor™ transcatheter aortic valve implantation (TAVI) software-guided balloon-expandable system for treating symptomatic severe aortic stenosis.
View source ↗ - Newszacks.com·6d ago·Neutral
Here's How Abbott's EP Business Is Shaping Up for the Rest of 2026 ABT's EP business gains momentum as Volt adoption accelerates and new device launches expand its portfolio despite LAA market weakness.
View source ↗ - Newszacks.com·9d ago·Neutral
Should You Buy, Hold or Sell Abbott Stock Post-Q3 Earnings? ABT's strong Q3 results, broad-based segment growth and Nutrition spin-off plans support its outlook, despite softer 2026 sales guidance.
View source ↗ - News (RSS)zerohedge·9d ago·Neutral
There's Something Suspicious About The Texas Midterm "Blue Wave" There's Something Suspicious About The Texas Midterm "Blue Wave" On the night of the 2020 Presidential Elections most Americans recall going to bed feeling certain that Donald Trump had pulled off another solid victory. With Joe Biden drawing mostly small crowds on the campaign trail and spending most of the cycle rarely engaging with the public, it seemed as if Trump was a lock. When everyone awoke the next morning, they were shoc
View source ↗ - News (RSS)zerohedge·11d ago·Neutral
Trump And Texas' New Democrat Governor Are Headed For War Over The Border Trump And Texas' New Democrat Governor Are Headed For War Over The Border The midterms did more than change which party will control Congress for the next year. By electing Gina Hinojosa governor, Texas voters ended a decade-long partnership between Austin and Washington on the border and set the state on a collision course with the Trump administration over immigration enforcement. Texas Governor-elect Gina Hinojosa speak
View source ↗ - News (RSS)zerohedge·11d ago·Neutral
Rand Paul Slams Texas Governor-Elect's 'Venezuelan Socialist' Plan To Freeze Electricity Rates Rand Paul Slams Texas Governor-Elect's 'Venezuelan Socialist' Plan To Freeze Electricity Rates Sen. Rand Paul (R-KY) took aim at Texas Gov.-elect Gina Hinojosa on Tuesday over her pledge to freeze electricity rates on her first day in office, calling it a move "out of the Venezuelan socialist playbook."Nothing like your first act being out of the Venezuelan socialist playbook . . . This will not end we
View source ↗ - News (RSS)economictimes·12d ago·Neutral
Foreign investors keep faith in 83 stocks despite prolonged India selloff Mumbai: Life Insurance Corp (LIC), ONGC, BHEL, Indian Bank and Aditya Birla Capital are among 83 companies that have featured consistently in the shopping cart of foreign portfolio investors (FPI) over the past four quarters, even though overseas funds have been major sellers of Indian equities through this period.An ET analysis of latest shareholding data, after the September quarter, showed that these companies across th
View source ↗ - News (RSS)zerohedge·14d ago·Neutral
The Incoming Democrat Governor Of Texas Is Already Going After Elon Musk The Incoming Democrat Governor Of Texas Is Already Going After Elon Musk Texas Gov.-elect Gina Hinojosa (D-TX) has asked the state's parks department to hold off on a proposed sale of state land to SpaceX until she takes office, contacting the department's executive director before she is sworn in this January. The move puts part of Elon Musk's expansion plans in South Texas on hold. Texas Governor-elect Gina Hinojosa speak
View source ↗ - News (RSS)zerohedge·15d ago·Positive
Houston Mayor Curbs ICE Cooperation Days After Abbott Loses - And Says Texas' New Leaders Are On Board Houston Mayor Curbs ICE Cooperation Days After Abbott Loses - And Says Texas' New Leaders Are On Board Houston Mayor John Whitmire has ordered the city's police to stop calling ICE on anyone who isn't arrested for a jailable offense, and says he cleared it with the Democrats who just won Texas. "SB4 is not a priority of the new statewide elected officials," Whitmire told reporters Friday, three
View source ↗ - News247wallst.com·15d ago·Neutral
3 Medical Device Stocks That Keep Raising Dividends. One Just Hit 55 Years Hospitals reorder syringes, sensors, and implants whether the economy booms or stalls, and three device makers turn that habit into payouts that grow every year.
View source ↗ - News (RSS)zerohedge·15d ago·Negative
Texas Governor-Elect Wants Data Center Pause; White House Says 'Communities' Should Decide Texas Governor-Elect Wants Data Center Pause; White House Says 'Communities' Should Decide Texas Governor-elect Gina Hinojosa said Thursday that the state needs new laws on data centers and should stop building them until they exist, the same day the Nasdaq plunged on fears that Democratic wins would bring moratoriums on the AI buildout. Texas Governor-elect Gina Hinojosa speaks during a press conference f
View source ↗ - PodcastCompound And Friends·16d ago·Neutral
But now you gotta do that for Ohio and Georgia and Iowa and the big one was Texas, Louisiana is going the other way. Louisiana is going the other way. I actually think it's interesting. I actually take the new governor Wisconsin is going to embrace the data centers. So there are some states that are gonna do it, but Texas was the grail. And Texas was supposed to take all this extra data, all the spillover from the other states that ban it and then all of a sudden, Abbott lost. The way that we th
View source ↗ - 4chan /biz/biz·17d ago·Neutral
>>62863261 My parents still live in Tejas despite me begging them to move out of state by wife and I. Tejas was a total self-own brought on by absolute devotion to both Isr*ael and capitalism. Abbott has imported genuinely millions of Indians, "conservative refugees" from f****** Cali and Oregon, etc. while also providing their employees massive tax breaks. People talk about the US being an economic zone instead of a country, because a country has actual culture, and Tejas is the embodiment of t
View source ↗ - News (RSS)fortune·17d ago·Neutral
Elon Musk spent at least $225 million in Texas. The governor-elect who sued for Abbott emails and vowed a data center freeze won anyway Hinojosa has questioned a $1.66 billion tax break for Musk’s $16.8 billion Terafab chip plant, and Democrats now control the Texas House.
View source ↗ - 4chan /biz/biz·17d ago·Neutral
IREN fags are delusional. During the earning call later today, the ceo will announce that the data centers in Texas are delayed again because of Abbott (current governor) pause on data center constructions. The next governor did her campaign on restricting data centers even more than Abbott did.
View source ↗ - News (RSS)forbes·17d ago·Neutral
Texas Will Learn The Economic Cost Of Saying ‘No’ To Data Centers A freeze on data center permits invoked by Texas Gov. Abbott could become permanent policy under incoming Gov. Gina Hinojosa.
View source ↗ - News (RSS)zerohedge·18d ago·Neutral
"Ten Weeks Left": Texas Republican Urges Gov. Abbott To Curb Emergency Powers Before Democratic Takeover "Ten Weeks Left": Texas Republican Urges Gov. Abbott To Curb Emergency Powers Before Democratic Takeover Texas Republican Has A Plan For Abbott's Final Ten WeeksTexas Rep. Brian Harrison (R-Midlothian) posted on X that Republicans still hold power in Texas for the next ten weeks and urged defeated three-term Governor Greg Abbott to convene an immediate special legislative session to curb exec
View source ↗ - News (RSS)zerohedge·18d ago·Neutral
Texas's New Democrat Governor Vowed To Stop Helping ICE - Here's What She Can Actually Undo Texas's New Democrat Governor Vowed To Stop Helping ICE - Here's What She Can Actually Undo Democrat Gina Hinojosa's upset of Gov. Greg Abbott hands the state's border machinery to a lawmaker who spent the campaign attacking it. Texas Rep. Gina Hinojosa, D-Austin, puts a fist up as she speaks to the crowd during a Stop ICE Rally at Pan American Neighborhood Park in East Austin, Jan. 31, 2026 (Getty) Abbot
View source ↗ - News (RSS)zerohedge·18d ago·Neutral
"Extinction-Level Event": Takeaways From The GOP's Midterm Wipeout "Extinction-Level Event": Takeaways From The GOP's Midterm Wipeout Democrats flipped seven Republican-held Senate seats and seized the House on Tuesday, handing President Trump what Punchbowl News called "an extinction-level event" for the GOP. As of Wednesday morning, NBC News had the Senate at 54-44 with two races still out. In Mississippi, Democrat Scott Colom led Sen. Cindy Hyde-Smith by 43 votes with more than 95% counted. I
View source ↗ - News (RSS)zerohedge·18d ago·Neutral
Bearish Beyond The 'Blue Wave' Bounce Bearish Beyond The 'Blue Wave' Bounce Submitted by QTR's Fringe FinanceWell, the voters have spoken. Screamed, actually. And if last night’s election results were supposed to provide some kind of reprieve for the Trump administration, they did precisely the opposite. Democrats delivered a decisive, sweeping victory, taking control of both the House and Senate and flipping seats in places Republicans have considered safe for generations.“Democrats are on trac
View source ↗ - Newsmarketwatch.com·18d ago·Positive
These 12 stocks are good bets to beat the 10-year Treasury over the next decade Investment newsletters' favorite Dividend Aristocrat stocks
View source ↗ - News (RSS)zerohedge·18d ago·Neutral
Texas Turns Blue, Futures Turn Green: Why Wall Street Bought The Biggest Democrat Wave Since 1993 Texas Turns Blue, Futures Turn Green: Why Wall Street Bought The Biggest Democrat Wave Since 1993 Last night, America's voters handed Trump the biggest midterm rebuke in a generation.Then, a few hours later, Wall Street shrugged it off. Nasdaq futures, which had crashed as much as 2.4% as the blue wave turned into a tsunami, were up 0.9% by morning in New York, having ripped 929 points off the overn
View source ↗ - 4chan /biz/biz·18d ago·Negative
>>62853566 >Abbott will no longer be around to import infinite jeets Thank god.
View source ↗ - News (RSS)zerohedge·19d ago·Neutral
Futures Mixed As America Votes, Apple Slides And Oil Rebounds After "Defensive" US Strike On Iran Futures Mixed As America Votes, Apple Slides And Oil Rebounds After "Defensive" US Strike On Iran US futures are down but off session lows, with Nasdaq contracts edging higher, as America heads to the polls for the midterms, chips rebound even as Apple slides on a gross margin warning and Palantir tumbles on a soft outlook, and oil bounces off Monday's 8% plunge after the US struck Iran's Qeshm Isla
View source ↗ - News (Finnhub)CNBC·20d ago·Negative
Texas governor race tightens in prediction markets, but Abbott remains favored Prediction markets still show the Republican incumbent favored to win a fourth term, but the odds have narrowed in recent weeks.
View source ↗ - Newsprnewswire.com·20d ago·Neutral
…s blood clot-related complications in people with atrial fibrillation not caused by a heart valve issue ABBOTT PARK, Ill., Nov. 2, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), the global healthcare leader, announced today one-year results for its investigational Amulet 360™ Left Atrial Appendage (LAA) Occluder from the VERITAS study, which show meaningful closure rates of the left atrial appendage and a low incidence of stroke in people with atrial fibrillation (AFib) not caused by a heart valve iss…
View source ↗ - Newsprnewswire.com·21d ago·Positive
…ronary devices portfolio, complementing its advanced imaging, lesion preparation and stent technologies ABBOTT PARK, Ill., Nov. 1, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), the global healthcare leader, announced strong 30-day results from the TECTONIC Coronary Artery Disease (CAD) Intravascular Lithotripsy (IVL) Investigational Device Exemption (IDE) Study evaluating the use of its investigational SonicForceTM Coronary IVL System, which is designed to crack calcium buildup in coronary arteries.
View source ↗ - Newsprnewswire.com·24d ago·Positive
…of heart valve ailment 30-day early feasibility study results for Cephea will be presented at TCT 2026 ABBOTT PARK, Ill., Oct. 29, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), the global healthcare leader, announced today it has initiated the CROWN-MV pivotal trial evaluating the safety and effectiveness of its investigational Cephea™ Mitral Valve System in treating people with symptomatic mitral valve disease who are not candidates for surgery and transcatheter repair.
View source ↗ - Newszacks.com·26d ago·Neutral
Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic? Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
View source ↗ - Newszacks.com·26d ago·Neutral
Is Most-Watched Stock Abbott Laboratories (ABT) Worth Betting on Now? Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
View source ↗ - Newsseekingalpha.com·26d ago·Negative
… action afterwards. Nutrition spin-off may unlock MedTech/Diagnostic/Pharmaceutical's growth, improve margins, and provide investors with new S&P 500-eligible stock. ABT trades at a P/E of 18.79x, below its 5Y mean/MedTech sector, offering a compelling entry point for double-digit upside potential.
View source ↗ - Newsfool.com·27d ago·Neutral
This Dividend King Just Announced Great News for Investors Abbott Laboratories' third-quarter results were somewhat mixed, with the company's nutrition business still dragging down sales growth. The healthcare leader announced that it would spin off its nutrition segment into a standalone company, which could help boost revenue growth.
View source ↗ - News (RSS)investing·27d ago·Neutral
Abbott launches whole-genome sequencing MRD test for cancer
View source ↗ - Newsprnewswire.com·27d ago·Negative
Abbott launches whole-genome sequencing Oncodetect® molecular residual disease (MRD) test to detect traces of cancer during and after treatment Powered by whole-genome sequencing and MAESTRO * technology, the next-generation Oncodetect test takes a distinct approach to MRD, tracking up to 5,000 patient-specific variants with a limit of detection below one part per million under high-end inputs 1, 2, 3 The next-generation Oncodetect test builds on more than 20 years of trusted leadership in using
View source ↗ - News (Marketaux)valueandopportunity.com·27d ago·Positive
value and opportunity Abbott Laboratories is[+335 characters]
View source ↗ - Newsseekingalpha.com·27d ago·Positive
Abbott Laboratories: A New Growth Story Takes Shape Abbott Laboratories remains a Buy, driven by robust device and diagnostics growth and the strategic spin-off of its Nutrition business. Devices and diagnostics now comprise 70% of revenue, with Medical Devices up 7.8% and Diagnostics accelerating post-Exact Sciences acquisition. Spinning off Nutrition is expected to boost ABT's growth rate by 50–100 bps, expand gross margin by 200 bps, and improve operating margin by 100 bps.
View source ↗ - News (RSS)fool·29d ago·Positive
Abbott Laboratories vs. UnitedHealth: Does Health Innovation or Health Insurance Make for a Better Stock to Buy? Abbott's $7.4B free cash flow and 0.3x debt load contrast sharply with UnitedHealth's $16.1B free cash flow but higher leverage and government policy risk.
View source ↗ - Newsprnewswire.com·30d ago·Neutral
Abbott presents new ESMO data showing 30-percent absolute improvement in sensitivity with the whole-genome sequencing Oncodetect® test in colorectal cancer Beta-CORRECT study shows a 10.6-fold higher risk of recurrence, reinforcing the prognostic value of molecular residual disease (MRD) testing 1 Building on its leadership in colorectal cancer screening with the Cologuard ® test, Abbott is connecting innovations across the cancer care continuum, from early detection to post-treatment monitoring
View source ↗ - Newszacks.com·31d ago·Neutral
Abbott's Q3 Earnings Call Focuses on Nutrition Spin-Off and Outlook Abbott plans to spin off its $8.5B Nutrition business by 2027 while cutting its 2026 sales growth outlook amid diabetes pricing and electrophysiology challenges.
View source ↗ - News (Marketaux)thestockmarketwatch.com·32d ago·Neutral
Tech Sector Faces Headwinds as Earnings Season Intensifies AT&T (T) and Abbott Laborat[+248 characters]
View source ↗ - News (RSS)fool·32d ago·Positive
Abbott: 3 Key Takeaways for Long-Term Investors Pulsed field ablation and expanded cancer screening tools position the core business for accelerated growth beyond historical rates.
View source ↗ - News (RSS)fool·32d ago·Positive
Abbott (ABT) Q3 2026 Earnings Call Transcript Abbott plans nutrition spinoff by end of 2027 amid strong Q3 growth.
View source ↗ - News (RSS)investing·32d ago·Neutral
Abbott options flow points to downside caution after guidance cut
View source ↗ - News (Marketaux)gurufocus.com·32d ago·Positive
Abbott Laboratories (ABT) Reports Q3 Results and Plans Nutrition Business Spin-Off Abbott Laboratories AB[+258 characters]
View source ↗ - Newsfool.com·32d ago·Positive
Abbott: 3 Key Takeaways for Long-Term Investors Abbott announced a tax-free spin-off of its nutrition business. Third-quarter comparable sales grew 7% year over year.
View source ↗ - News (RSS)seekingalpha·32d ago·Neutral
Midday Need to Know: Putin signals Ukraine talks, Abbott cuts outlook & more
View source ↗ - News (Marketaux)gurufocus.com·32d ago·Neutral
Abbott Laboratories (ABT) to Spin Off Global Nutrition Business Into Independent Public Company Abbott Laboratories AB[+287 characters]
View source ↗ - News (Marketaux)gurufocus.com·32d ago·Positive
Abbott Laboratories (ABT) Anticipates Growth and Margin Expansion Post Spin-Off On October 21, 2026, Abbott <em[+322 characters]
View source ↗ - Newsseekingalpha.com·32d ago·Neutral
…ast Abbott Laboratories will spin off its Nutrition division, aiming to sharpen focus on higher-growth diagnostics, medical devices, and established pharmaceuticals. ABT's Q3 revenues rose 14.5% year-on-year to $13.01bn, with Diagnostics (boosted by the Exact Sciences acquisition) and Medical Devices as key growth drivers. 2026 adjusted EPS guidance narrowed to $5.50–$5.55; management expects the spin-off to enable higher growth and improved profitability for ABT.
View source ↗ - News (RSS)ft·32d ago·Neutral
Abbott to spin off nutrition unit at centre of baby formula lawsuits US healthcare group plans to create standalone public company with $8.5bn in annual sales
View source ↗ - News (RSS)rte·32d ago·Neutral
Abbott cuts its 2026 full year sales growth view Abbott Laboratories has today cut its 2026 sales growth forecast and said it plans to separate its nutrition business, which includes baby formula, into a publicly traded company.
View source ↗ - Newsseekingalpha.com·32d ago·Positive
Abbott Laboratories (ABT) Q3 2026 Earnings Call Transcript Abbott Laboratories (ABT) Q3 2026 Earnings Call Transcript
View source ↗ - Newsmarketbeat.com·32d ago·Neutral
What Abbott Laboratories (ABT) Said on Its Q3 Earnings Call Abbott Laboratories NYSE: ABT reported third-quarter sales growth of 7% and adjusted earnings-per-share growth of 9%, while announcing plans to separate its nutrition business into an independent publicly traded company through a tax-free distribution to shareholders.
View source ↗ - News (RSS)zerohedge·32d ago·Neutral
Futures Rise As SpaceX Blowout Revives AI Trade; Brent Back Above $110 Futures Rise As SpaceX Blowout Revives AI Trade; Brent Back Above $110 US futures are higher as blowout results from SpaceX and a monster preannouncement from Super Micro gave the battered AI trade a reason to bounce, while Elon Musk's open endorsement of a SpaceX-Tesla merger added to the buzz; but with more attacks on shipping around the Strait of Hormuz, oil is back on the rise and as a result Brent is again above $110 whi
View source ↗ - Newszacks.com·32d ago·Negative
ABT Stock Down Post Q3 Earnings Miss, Revenues Rise Y/Y, Margins Up Abbott's Q3 earnings miss weighs on its stock despite double-digit revenue growth and expanding margins, while lower 2026 sales guidance raises concerns.
View source ↗ - Newszacks.com·32d ago·Negative
Abbott (ABT) Misses Q3 Earnings Estimates Abbott (ABT) came out with quarterly earnings of $1.42 per share, missing the Zacks Consensus Estimate of $1.43 per share. This compares to earnings of $1.3 per share a year ago.
View source ↗ - Newsreuters.com·32d ago·Negative
Abbott lowers 2026 sales growth forecast on medical device weakness Abbott lowers 2026 sales growth forecast on medical device weakness
View source ↗ - Newsprnewswire.com·32d ago·Neutral
Abbott Reports Third-Quarter 2026 Results and Reaffirms Full-Year EPS Guidance Third-quarter reported sales growth of 14.5 percent; comparable sales growth of 7.0 percent Third-quarter GAAP diluted EPS of $0.53; adjusted diluted EPS of $1.42 Expands portfolio with key new product approvals ABBOTT PARK, Ill., Oct. 21, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the third quarter ended Sept.
View source ↗ - Newsprnewswire.com·32d ago·Neutral
… a tax-free distribution to Abbott shareholders Separation expected to be completed by the end of 2027 ABBOTT PARK, Ill., Oct. 21, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), the global healthcare leader, today announced its intention to separate its Nutrition business into an independent, publicly traded company that will be a global leader in the rapidly expanding healthy nutrition market with approximately $8.5 billion in annual sales and a portfolio of iconic brands.
View source ↗ - News (RSS)financialpost·34d ago·Neutral
Capital Power to release third quarter 2026 results on November 2 EDMONTON, Alberta, Oct. 19, 2026 (GLOBE NEWSWIRE) — Capital Power Corporation (TSX: CPX) will release its 2026 third quarter results before the markets open on November 2, 2026. A conference call and webcast to discuss the results will be held the same day at 9:00 a.m. ABT (8:00 a.m. MT / 10:00 a.m. ET). Analyst […]
View source ↗ - Newszacks.com·34d ago·Positive
2 Industries Beyond AI With Long-Term Demand Drivers for 2027 As AI dominates Wall Street, healthcare and waste management offer long-term demand drivers for 2027, backed by demographic trends and essential services.
View source ↗ - Newsbenzinga.com·34d ago·Neutral
Top Wall Street Forecasters Revamp Abbott Expectations Ahead Of Q3 Earnings Abbott Laboratories (NYSE:ABT) will release its third quarter earnings report before the opening bell on Wednesday, Oct. 21.
View source ↗ - Newszacks.com·37d ago·Neutral
Countdown to Abbott (ABT) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS Beyond analysts' top-and-bottom-line estimates for Abbott (ABT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2026.
View source ↗ - News (Marketaux)dividend-growth-stocks.com·37d ago·Neutral
Abbott Laboratories (ABT) Dividend Stock Analysis Abbott Laboratories (ABT) Dividend Stock Analysis
View source ↗ - News247wallst.com·38d ago·Neutral
3 Overlooked Healthcare Dividend Stocks That Could Keep Paying for Decades Most income investors chase flashy yields and overlook the quiet compounders that have raised their dividends through recessions, rate shocks, and global pandemics.
View source ↗ - Newszacks.com·40d ago·Neutral
Should You Add Abbott Stock to Your Portfolio Ahead of Q3 Earnings? ABT's Q3 earnings are likely to have benefited from Diagnostics growth, Medical Device momentum and Nutrition innovations, while its valuation below historical levels draw investor interest.
View source ↗ - Newszacks.com·41d ago·Positive
Abbott (ABT) Gains As Market Dips: What You Should Know Abbott (ABT) closed the most recent trading day at $101.82, moving +2.23% from the previous trading session.
View source ↗ - News (RSS)fool·41d ago·Positive
Abbott Laboratories vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy in 2026? Abbott trades at a 18x forward P/E with $7.4B in free cash flow, while Intuitive Surgical commands a 39x multiple backed by zero debt and 20% revenue growth.
View source ↗ - Newsfool.com·41d ago·Positive
Abbott Laboratories vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy in 2026? Abbott Laboratories provides stability through a massive, diversified portfolio of diagnostics, nutrition, and medical devices. Intuitive Surgical dominates the robotic-assisted surgery market with high growth and exceptional cash reserves.
View source ↗ - News (RSS)fool·43d ago·Neutral
History Says Abbott Stock Could More Than Double by 2036. Here’s Why I Just Added It to My Portfolio. Abbott has a low-risk profile with significant upside potential.
View source ↗ - Newsfool.com·43d ago·Neutral
History Says Abbott Stock Could More Than Double by 2036. Here's Why I Just Added It to My Portfolio. Abbott has grown its earnings per share at a nearly 10% compound annual rate over the past decade. Its stock price could more than double by 2036 using a more conservative 8% growth rate.
View source ↗ - Newszacks.com·44d ago·Neutral
Cancer Stocks to Consider as Oncology Innovation Accelerates Oncology stocks are gaining relevance as cancer care evolves, with Pfizer, Merit Medical Systems and Abbott advancing treatments, diagnostics and screening technologies.
View source ↗ - News (Marketaux)economictimes.indiatimes.com·45d ago·Positive
US President Donald Trump buys $1 million-plus stakes in Meta, Microsoft, McDonald’s; adds SpaceX debt His administration has strongly supporte[+331 characters]
View source ↗ - Newszacks.com·45d ago·Positive
Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views? The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
View source ↗ - Newszacks.com·45d ago·Neutral
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
View source ↗ - Newsprnewswire.com·46d ago·Negative
Abbott introduces Ensure® Max Protein 3-in-1 Muscle Support, bringing the benefits of a supplement stack into one scoop New powder combines 30 grams of high‑quality protein to help build muscle tissue,† 5 grams of creatine monohydrate to support muscle recovery‡* and 3 grams of calcium HMB (beta-hydroxy-beta-methylbutyrate) to help preserve muscle Ensure Max Protein 3-in-1 formula provides muscle support in a single daily serving to support muscle health goals—and is available in chocolate and v
View source ↗ - Newsbenzinga.com·46d ago·Positive
This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
View source ↗ - Newszacks.com·47d ago·Positive
Abbott (ABT) Stock Drops Despite Market Gains: Important Facts to Note Abbott (ABT) closed the most recent trading day at $98.16, moving 1.94% from the previous trading session.
View source ↗ - News (RSS)zerohedge·47d ago·Neutral
Debate Over Islam Divides A Texas County Debate Over Islam Divides A Texas County Authored by Darlene McCormick Sanchez via The Epoch Times, In Collin County, home to a growing Muslim population, residents of McKinney have been gathering signatures to recall the city council members and the mayor who approved a mosque site plan after a tense city council meeting in August. A few miles south, on the 25th anniversary of 9/11, protesters gathered outside a Plano mosque, waving American flags and ho
View source ↗ - Newsprnewswire.com·48d ago·Negative
…ents take a more active role in their care and stay connected to their care teams between doctor visits ABBOTT PARK, Ill., Oct. 5, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), the global healthcare leader, today announced U.S. Food and Drug Administration (FDA) approval for updates to the CardioMEMS HF System that enable new patient-facing capabilities through the CardioGuide HF App.
View source ↗ - Newszacks.com·51d ago·Positive
4 Low-Beta Healthcare Stocks to Buy Amid Fears of Another Rate Hike ABT, CORT, PGEN and BHC offer low-beta healthcare exposure as rate-hike fears and market volatility persist.
View source ↗ - Newsfool.com·52d ago·Positive
Abbott Laboratories vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy in 2026? Abbott Laboratories offers a highly diversified revenue stream across medical devices, diagnostics, and nutrition. Intuitive Surgical maintains a dominant lead in robotic-assisted surgery with high recurring revenue from instruments and services.
View source ↗ - News (RSS)zerohedge·52d ago·Negative
The Data Center Boom Faces Mounting Obstacles The Data Center Boom Faces Mounting Obstacles By Brian Martucci of UtilityDive, The U.S. data center boom has entered a new, contradictory phase. On the one hand, both data center construction activity and credible forecasts for near-term capacity additions to the electric grid to serve data centers remain robust. The Electric Power Research Institute, for example, said in February that data centers will represent up to 17% of U.S. electricity demand
View source ↗ - Newszacks.com·53d ago·Neutral
Abbott (ABT) Sees a More Significant Dip Than Broader Market: Some Facts to Know The latest trading day saw Abbott (ABT) settling at $98.83, representing a -2.1% change from its previous close.
View source ↗ - News (RSS)zerohedge·54d ago·Neutral
Texas Governor Declares Disaster Over Soaring Diesel Prices Texas Governor Declares Disaster Over Soaring Diesel Prices Texas ranchers and truckers could start seeing some relief at the fuel pump starting this week after Gov. Greg Abbott proclaimed a statewide disaster on Sept. 28 to ease diesel shortages. "Texas agriculture and freight run on diesel," Abbott said in a statement. "Record prices put both industries at risk and raise costs for every Texas family." Record-high diesel prices in the
View source ↗ - News (RSS)forbes·54d ago·Neutral
Abbott Moves Again To Slam The Brakes On Texas Data Center Growth Texas Governor Greg Abbott moved again to slow the expansion of data centers in his state amid a close re-election campaign.
View source ↗ - News247wallst.com·54d ago·Negative
3 Historically Stable Dividend Raisers in Medical Devices Offering Solid Yields With Fortress-Like Growth Pacemakers and glucose monitors keep selling whether the economy booms or collapses, and three medical device giants have spent decades turning that predictable demand into paychecks that grow every single year.
View source ↗ - News (RSS)zerohedge·58d ago·Neutral
Efforts To Curb Data Center Speculation Gain Ground Across The US Efforts To Curb Data Center Speculation Gain Ground Across The US By Brian Martucci of UtilityDive, “A fraction of proposed data centers will get built. Utilities are wising up.” That was the headline on a May 2025 Utility Dive article that explored the conundrum speculative data center requests pose for U.S. electric utilities. More than a year later, it’s unclear how much has changed. Sections of the Stargate Oracle AI data cent
View source ↗ - Newsfoxbusiness.com·59d ago·Neutral
CEO warns high diesel costs could trigger a 'vicious cycle' of surging food prices Pivot Bio CEO Chris Abbott warns food prices could remain elevated for at least a year as rising diesel costs drive up expenses for farmers during harvest season.
View source ↗ - Newszacks.com·59d ago·Neutral
Abbott (ABT) Registers a Bigger Fall Than the Market: Important Facts to Note Abbott (ABT) concluded the recent trading session at $101.07, signifying a -2.34% move from its prior day's close.
View source ↗ - News (Marketaux)finance.yahoo.com·60d ago·Positive
What Makes Abbott Laboratories (ABT) an Attractive Opportunity? In its second-quarter 2026 investor lett[+384 characters]
View source ↗ - Newszacks.com·60d ago·Neutral
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
View source ↗ - News (RSS)zerohedge·61d ago·Negative
Texas Governor Orders Halt To New Data Centers Weeks After Issuing Moratorium Texas Governor Orders Halt To New Data Centers Weeks After Issuing Moratorium One month after Texas Governor Greg Abbott ordered a pause on Texas data center approvals pending an audit, overnight the governor doubled down and ordered the state’s environmental watchdog to withhold permits for new data centers until an audit of risks to the power grid is complete. No authorizations can be given until the Electric Reliabi
View source ↗ - News (RSS)cnbc·62d ago·Positive
Texas Gov. Abbott orders data center permit halt weeks after issuing moratorium Data centers have been a flash point in the 2026 midterm elections, including Abbott's bid for reelection against Democratic state Rep. Gina Hinojosa.
View source ↗ - News (RSS)zerohedge·62d ago·Negative
Houston-Area Birth Tourism Center Shut Down In Legal Action Houston-Area Birth Tourism Center Shut Down In Legal Action Authored by Kimberly Hayek via The Epoch Times, A birth tourism operation in the Houston area has agreed to close in a settlement, Texas Attorney General Ken Paxton announced on Friday. An advertisement for a Houston-area “birth tourism” operation known as De’Ai Postpartum Care Center. The Texas attorney general filed a lawsuit against the center, claiming it has operated an un
View source ↗ - Newsfool.com·62d ago·Neutral
Abbott Laboratories vs. Intuitive Surgical: Recent Quarterly Revenue Trends Reveal a Classic Investing Truth Abbott Laboratories (ABT +0.54%) primarily generates its revenue by researching, developing, manufacturing, and distributing a diverse portfolio of medical devices, diagnostic test systems, nutritional formulas, and generic pharmaceutical products across international healthcare networks.
View source ↗
Earnings
Thu, Jan 28(in 2 months)
Consensus estimate $1.64 per share
Typical surprise +0.0% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Oct 21$1.42 vs $1.42beat
- Thu, Jul 16$1.31 vs $1.28beat
- Thu, Apr 16$1.15 vs $1.14beat
- Thu, Jan 22$1.50 vs $1.50beat
- Wed, Oct 15$1.30 vs $1.30beat
- Thu, Jul 17$1.26 vs $1.26beat
Estimates and results for ABT via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by ABT officers and directors.
- Bought
- $4.4m
- Sold
- $47.7m
6 trades
11 trades
- Moreland Mary Ksold
- Mccoy John A. Jr.sold
- Ford Robert Bsold
- Ford Robert Bsold
- Morrone Louis H.sold
- Stratton John Gbought
- Starks Daniel Jbought
- Boudreau Philip Pbought
83 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Ro Khannahouse · CA17 · disclosed Nov 9, 2026 (33d later)Buy$15,001 - $50,000
- Thomas Keanhouse · NJ07 · disclosed Oct 30, 2026 (43d later)Sell$1,001 - $15,000
- Pete Sessionshouse · TX17 · disclosed Oct 28, 2026 (26d later)Sell$50,001 - $100,000
- Gilbert Cisneroshouse · CA31 · disclosed Oct 12, 2026 (24d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Oct 9, 2026 (35d later)Buy$1,001 - $15,000
- Rick Allenhouse · GA12 · disclosed Aug 19, 2026 (36d later)Sell$15,001 - $50,000
- Rich McCormickhouse · GA06 · disclosed Aug 17, 2026 (18d later)Sell$1,001 - $15,000
- Mike Kellyhouse · PA16 · disclosed Aug 12, 2026 (26d later)Sell$1,001 - $15,000
- Alan Armstrongsenate · disclosed Jul 21, 2026 (116d later)Sell$15,001 - $50,000
- Richard Ray Larsenhouse · WA02 · disclosed Jul 13, 2026 (5d later)Sell$1,001 - $15,000
- Rich McCormickhouse · GA06 · disclosed Jul 10, 2026 (28d later)Buy$1,001 - $15,000
- Rich McCormickhouse · GA06 · disclosed Jul 10, 2026 (28d later)Buy$1,001 - $15,000
- Rich McCormickhouse · GA06 · disclosed Jul 10, 2026 (28d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Jul 8, 2026 (36d later)Buy$1,001 - $15,000
- Gilbert Cisneroshouse · CA31 · disclosed Jul 3, 2026 (17d later)Buy$1,001 - $15,000
- Julie Johnsonhouse · TX32 · disclosed Jun 15, 2026 (34d later)Sell$1,001 - $15,000
- Gilbert Cisneroshouse · CA31 · disclosed Jun 9, 2026 (25d later)Sell$1,001 - $15,000
- Rick Allenhouse · GA12 · disclosed Jun 8, 2026 (53d later)Sell$15,001 - $50,000
- Josh Gottheimerhouse · NJ05 · disclosed Jun 4, 2026 (8d later)Sell$1,001 - $15,000
- Laura Friedmanhouse · disclosed Apr 20, 2026 (27d later)Sell$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
